posted by
sbisson at 01:53pm on 22/06/2003
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
The first biotech preventative for asthma has just received FDA approval. Now for it to get across the Atlantic, and to find out if it works on my asthmatic cough...
"Aimed at treating moderate to severe asthma triggered by allergies, Xolair works by disabling a naturally occurring antibody called IgE that triggers the release of chemicals that cause inflammation.
Xolair treats the underlying cause of asthma triggered by allergies, rather than the symptoms that inhaled corticosteroids address, the companies said."
(From this Reuters article found via Google News)
"Aimed at treating moderate to severe asthma triggered by allergies, Xolair works by disabling a naturally occurring antibody called IgE that triggers the release of chemicals that cause inflammation.
Xolair treats the underlying cause of asthma triggered by allergies, rather than the symptoms that inhaled corticosteroids address, the companies said."
(From this Reuters article found via Google News)
There are 3 comments on this entry. (Reply.)